fda compounding semaglutide crackdown september 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Slimming down competition over weight-loss

Various distributors claim that the peptides are sourced from APEX Pharma, asserting that the compounds are synthesized in state-of-the-art biotech facilities featuring GMP-aligned development practices and rigorous analytical purity verification

Contrave uses a 4-week titration schedule specifically to minimize these early side effects

Are weight loss medications the answer for Binge Eating Disorder (BED)

A stroke, a severe infection, or a catastrophic allergic reaction to an unknown substance is a possible outcome

The Medicare GLP-1 Bridge (launching July 1, 2026, through December 31, 2027) provides weight-loss access to Wegovy at a fixed $50 per month copay outside Part D this does not count toward the deductible, TrOOP, or the $2,100 cap

10.2337/dci18-0033 71